Latest News

Focusing on cutting-edge technologies and research advancements,
sharing Aniphe BioLab’s achievements in scientific innovation, Professional insights
and practical experience in the fields of laboratory animals and preclinical research.

Publish an article

2026-10-29

Naming Genetically Engineered Mice (Part II): From Being Understandable to Being Written Correctly

2026-10-29

How should a multi-disease composite mouse model be constructed? Let’s take a look at the CKM approach.

2026-08-12

2026 CKM Guidelines Released: Chronic Diseases Enter the Era of Integrated Cardiorenal-Metabolic Management—It’s Time to Rethink Animal Models

2026-08-12

A Guide to Safe Mouse Handling | Manual on Mouse Transport Protocols and Troubleshooting

Good news! Jiangsu Aniphe BioLab has successfully obtained its License for the Production of Laboratory Animals!

Recently, following review and approval by the Jiangsu Provincial Department of Science and Technology, the Aniphe BioLablogical Experimental Animal Center has successfully obtained the “License for the Production of Laboratory Animals.”

Image source: Aniphe BioLab

With this, Aniphe BioLab has successfully obtained both the “License for the Use of Laboratory Animals” and the “License for the Production of Laboratory Animals,” establishing our company’s SPF‑grade laboratory animal facility. It is now equipped to conduct genetic engineering mouse breeding, maintain SPF‑grade rodent experimental animals (mice and rats), generate disease animal models, and carry out related animal‑based scientific research. Its qualification requirements provide robust infrastructure support for the operation of a public platform for medical research and preclinical pharmacological evaluation studies, while also enabling us to offer clients more comprehensive, high‑quality services.

Image source: Aniphe BioLab

Looking back, the on-site review panel—through listening to presentations, administering theoretical exams, conducting hands-on experiments, reviewing documentation on system operations, and inspecting animal‑experiment facilities—fully endorsed the construction of Aniphe BioLab’s animal laboratory and its standardized, scientifically sound management, while also offering constructive recommendations to help the company further refine and strengthen its policies and procedures. In the end, the expert panel unanimously approved the on-site assessment of the facility for the production of laboratory animals.

Expert panel review on-site

About Aniphe BioLab

Ailinfei Company Environment

Jiangsu Aniphe BioLab Inc. was established in 2018 and has since developed a comprehensive SPF‑grade laboratory animal facility that integrates animal production and experimental services, covering research areas such as oncology, neuroscience, and metabolism. The facility spans a total area of 827 square meters.

Facility and Environment Section Display

The Laboratory Animal Center is designed in strict accordance with regulatory standards, featuring a state-of-the-art ventilation system that segregates pedestrian, material, and animal traffic flows to minimize the risk of cross-contamination. The facility is equipped with an integrated temperature, humidity, and pressure monitoring and control system, enabling precise and efficient environmental monitoring throughout the premises.

Exhibition of the饲养笼 section

The animal facility houses approximately 5,000 housing cages for mice and rats, all equipped with IVC‑compatible cage systems. Each mouse cage features a floor area of ≥535 cm² and an HEPA filter surface area of ≥230 cm², further minimizing environmental stress and providing ample, comfortable floor space along with abundant opportunities for activity.

Partial display of mouse and rat housing cages

Aniphe BioLab centers on the development of disease animal models, leveraging cutting-edge advances in human medicine to create novel strains and conduct translational research and market promotion of related products. In addition to meeting the needs of preclinical studies, the center provides complementary experimental platforms for cell biology, molecular analysis, protein characterization, and pathology, thereby supporting customers’ comprehensive research requirements.